Doctor profile · Federal record

Dr. Rachel Kapelow

Rheumatology Physician (CMS: Rheumatology) · Delray Beach, FL

  • NPI 1366804098
  • Accepts Medicare
  • MIPS 100.0 / 100 · 2023
  • 10 yrs in practice
  • Female
  • Group practice
  • No sanctions

Practice & contact

NPPES Updated May 11, 2026
Primary practice
14610 S Military Trl Ste G3
Delray Beach, FL 334843801
(561) 819-3100

Credentials & registration

NPPES · NUCC
NPI registered
March 2016 — 10 yrs on file
Profile last updated
August 29, 2023
Year of graduation
2016 — 10 yrs since
Specialty taxonomy
207RR0500X — NUCC code
State license (1)
Florida #ME149102

Federal sanctions & exclusions

OIG LEIE Updated May 11, 2026

No sanctions, exclusions or revocations on file

Checked against OIG LEIE on NPI 1366804098. Last verified May 11, 2026.

Medicare procedures · 2023

Top services delivered

CMS Provider Utilization
Total services
176,782
Distinct HCPCS
10
Medicare allowed
$2,643,189
HCPCS Description Services Patients Avg allowed
J0717 Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) 78,200 72 $5
J0897 Injection, denosumab, 1 mg 17,640 243 $23
J3262 Injection, tocilizumab, 1 mg 17,360 15 $6
J3111 Injection, romosozumab-aqqg, 1 mg 15,333 31 $10
J0129 Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) 13,150 61 $42
J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg 11,192 639 $1
J1602 Injection, golimumab, 1 mg, for intravenous use 10,600 28 $13
99214 Established patient office or other outpatient visit, 30-39 minutes 2,376 908 $130
J3304 Injection, triamcinolone acetonide, preservative-free, extended-release, microsphere formulation, 1 mg 1,636 29 $17
96401 Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle 1,037 382 $73

In context: peer comparison

Among 9 peers in Delray Beach Rheumatology Physician, average services per provider: 2,434. This provider delivers 73× the peer median.

Open Payments

Industry payments received

CMS Open Payments
All-time total
$1,259
Transactions
73
Manufacturers
14
Payer (manufacturer) Industry Txns Amount
Ucb, INC. 17 $304.10
E.R. Squibb & Sons, L.L.C. 11 $164.54
Novartis Pharmaceuticals Corporation 12 $135.95
Scilex Pharmaceuticals INC. 5 $112.57
AstraZeneca Pharmaceuticals Lp 6 $104.45
Amgen INC. 4 $89.90
GlaxoSmithKline, LLC. 4 $65.28
Pfizer INC. 4 $61.01
Janssen Biotech, INC. 2 $57.59
Radius Health, INC. 2 $48.46
Genentech USA, INC. 2 $44.20
Organon LLC 2 $33.75
Lilly USA, LLC 1 $19.35
Bioventus LLC 1 $17.46

By nature of payment

Food and Beverage
$1,259

Medicare Part D · 2023

Top prescriptions

CMS Part D Prescriber
Total claims
951
Patients
539
Total drug cost
$65,130
Drug Type Claims Patients Total cost
Methylprednisolone Generic 264 203 $3,773
Tramadol Hcl Generic 150 82 $804
Prednisone Generic 123 63 $932
Hydroxychloroquine Sulfate Generic 98 52 $8,853
Oxycodone-Acetaminophen (Oxycodone Hcl/Acetaminophen) Brand 59 35 $1,085
Methotrexate (Methotrexate Sodium) Brand 54 34 $1,996
Hydrocodone-Acetaminophen (Hydrocodone/Acetaminophen) Brand 43 21 $1,415
Alendronate Sodium Generic 40 23 $382
Allopurinol Generic 24 11 $545
Folic Acid Generic 20 15 $103

Frequently asked questions

Auto-generated from federal data
What is Dr. Rachel Kapelow's medical specialty?
Dr. Rachel Kapelow practices Rheumatology Physician in Delray Beach, FL.
Where does Dr. Rachel Kapelow practice?
Dr. Rachel Kapelow practices at 14610 S Military Trl Ste G3, Delray Beach, FL 334843801. Office phone: 5618193100.
What is Dr. Rachel Kapelow's NPI?
Dr. Rachel Kapelow's National Provider Identifier (NPI) is 1366804098, issued by NPPES.
Does Dr. Rachel Kapelow accept Medicare assignment?
Yes. Dr. Rachel Kapelow accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Rachel Kapelow commonly perform?
Top Medicare-reported procedures in 2023: Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) (HCPCS J0717); Injection, denosumab, 1 mg (HCPCS J0897); Injection, tocilizumab, 1 mg (HCPCS J3262). Source: CMS Medicare Physician & Other Practitioners file.